Abstract
Cardio respiratory exercise testing provides an objective measurement of aerobic exercise capacity in patients with congenital heart disease. Many patients with congenital heart disease have decreased exercise capacity despite a lack of symptoms. Patients with simple lesions tend to have better exercise capacity than those with complex lesions, but individual variation exists. The reasons for this impairment in exercise capacity cannot be explained by ventricular dysfunction alone. Chronotropic impairment, disturbances of pulmonary function and deconditioning also play a key role. In patients with congenital heart disease, cardio respiratory exercise testing has prognostic value and could be important in deciding the need for re-interventions.
Keywords: Exercise, congenital, heart, physical activity, aerobic, capacity-prognosis, low morbidity, ventricular dysfunction, Chronotropic impairment, prognostic value, musculoskeletal systems
Related eBooks
Related Articles
-
Levosimendan: From Basic Science to Clinical Trials
Recent Patents on Cardiovascular Drug Discovery (Discontinued) Neopterin: From Forgotten Biomarker to Leading Actor in Cardiovascular Pathophysiology
Current Vascular Pharmacology Prevention of Left Ventricular Remodelling after Acute Myocardial Infarction: An Update
Recent Patents on Cardiovascular Drug Discovery (Discontinued) Sinus Node If Channel Inhibition – A New Therapeutic Approach to Heart Rate Lowering
Current Drug Therapy Angiotensin Receptor Blockers in Hypertension and Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry B-Type Natriuretic Peptide for Diagnosis and Therapy
Recent Patents on Cardiovascular Drug Discovery (Discontinued) Dietary Prevention of Coronary Heart Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Biomarkers in Systemic Sclerosis-Related Pulmonary Arterial Hypertension
Current Vascular Pharmacology Ivabradine: a Selective If Current Inhibitor in the Treatment of Stable Angina
Recent Patents on Cardiovascular Drug Discovery (Discontinued) Radionuclide Imaging in Patients with Ischemic Heart Failure
Current Medical Imaging Palliative Combined Percutaneous Balloon Aortic Valvuloplasty and Unprotected Left Main Stenting in End Stage Renal Disease
Current Cardiology Reviews Effects of Metabolic Approach in Diabetic Patients with Coronary Artery Disease
Current Pharmaceutical Design Acute Right Ventricular Failure in the Setting of Acute Pulmonary Embolism or Chronic Pulmonary Hypertension: A Detailed Review of the Pathophysiology, Diagnosis, and Management
Current Cardiology Reviews Cardiac Remodeling Induced by Smoking: Concepts, Relevance, and Potential Mechanisms
Inflammation & Allergy - Drug Targets (Discontinued) The C-Reactive Protein Levels in Left Ventricular Dysfunction of Different Etiology
Inflammation & Allergy - Drug Targets (Discontinued) Refining the Indications of Implantable Cardioverter Defibrillator in Patients with Left Ventricular Dysfunction
Reviews on Recent Clinical Trials Preoperative Levosimendan. A New Way for Organoprotection
Current Pharmaceutical Design Treatment of Takotsubo Cardiomyopathy
Current Pharmaceutical Design Cardiac Toxicities of Antiangiogenic Therapies
Current Angiogenesis (Discontinued) ATP-Sensitive K+ Channel Openers: Old Drugs with New Clinical Benefits for the Heart
Current Vascular Pharmacology